Transforming Weight Management Trials: Embracing Digital Health Technologies

This webinar will focus on common requirements and overarching challenges to ensuring quality data and successful end-to-end completion in capturing endpoints, specifically in clinical trials for obesity.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/weight-management

Event overview

Global obesity has more than doubled since 1990, with one in eight people currently living with obesity. As of 2022, there are over 2.5 billion adults who are overweight, of which approximately 890 million are obese. Childhood and adolescent obesity has quadrupled, posing long-term health risks. Obesity is linked to increased risk of noncommunicable diseases like Type 2 diabetes, heart disease and certain cancers. There are many unanswered questions related to obesity, often revolving around the most effective interventions for long-term weight management and the underlying genetic, behavioral and environmental factors that contribute to obesity. This has led to an exponential increase in interest and demand for effective, long- acting novel treatment options over the last 5 years. As of the latest available data, there are 1,072 ongoing clinical trials involving obesity.

This webinar will focus on the various digital health technologies (DHTs) that measure endpoints currently being used in weight management studies and the challenges and considerations around the use of these technologies.

Three key take-aways

• Assess the different possibilities of use and criteria in choosing DHTs for clinical trials.
  
• Understand the benefits of using of multiple DHTs in weight management clinical trials and what to consider.
  
• Learn best practices from examples where technologies were used in combination, such as weight scales, BIAs, eCOAs, CGM, and ECGs.
  

Speakers:

Tapan K. Raval, M.D.
Director, Strategic Solutions, Connected Devices
IQVIA

With a background in medicine and clinical research education, Tapan K. Raval, M.D., has more than 20 years of experience working in the CRO industry managing centralized cardiac safety operations and data management. He also is experienced in creating end-to-end solutions for using medical devices data as a part of the safety and efficacy endpoints for clinical drug development and device trials.

In his current role with IQVIA, Raval works on the protocol, program digital endpoint strategy and facilitates selection of the best fit medical grade digital technology for the specific protocol or program from scientific, medical and regulatory aspects. Raval has been a speaker on multiple forums and has authored white papers and publications related to scenarios using medical devices within clinical trials directly from a participant’s home and through participating sites. He is based in Mumbai, India.



Brian J. Wulff, M.S.
Director, Strategic Solutions Lead, Endocrinology and Imaging
IQVIA

As a strategic solutions lead within the connected devices team at IQVIA, Brian J. Wulff, M.S., is responsible for developing the strategy and design requirements for device- driven data collection. He is focused primarily on devices associated with endocrinology, but he also supports imaging. Wulff has worked in the pharmaceutical and CRO industry of over 24 years. His previous roles have included working in and leading project management, data management and statistical programming organizations.

Over the course of his career, Wulff has held roles at Eli Lilly and Co., i3 Statprobe, Indiana University Health, PharmaNet, inVentiv Health Clinical and Syneos Health. He earned his bachelor’s in telecommunications and master’s in information and communication science from Ball State University in Muncie, Indiana.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/weight-management